GI Cancer

Read the most current news and learn about the latest research developments in gastrointestinal (GI) cancer. Cancer Nursing Today provides the latest clinical findings and perspectives on GI cancers, including liver cancer immunotherapy, risk-prediction models, the link between diet and colorectal cancer, and more. From radiotherapy and chemotherapy to the role of screening in early detection, learn how GI cancer care and research are moving forward.

Global Liver Cancer Rates to Increase by 55% by 2040
According to the American Cancer Society, liver cancer is diagnosed in over 800,000 people worldwide each year and accounts for over 700,000 cancer-related deaths each year, making it a leading cause of cancer deaths worldwide. Liver cancer is the sixth most common form of cancer worldwide, and is the most commonly diagnosed cancer in countries outside of the United States. It is especially common in low- and middle-income countries (LMICs), with the three highest rates of liver cancer occurrence in 2020 seen in Mongolia, Egypt, and Laos. ...
Advertisement

Latest News

Advertisement

Knowledge Hubs

Best Practices
Best Practices

Conference Highlights

Cecilia BrownConferences | October 5, 2022
The GVHD rate was around 5% in patients receiving Orca-T, a high-precision, regulatory T-cell-engineered donor product.
Read More
Cecilia BrownConferences | October 5, 2022
GVHD occurred more with a fludarabine-based flipped conditioning regimen than with a cyclophosphamide-based flipped regimen.
Cecilia BrownConferences | October 5, 2022
The presence and number of clonal plasma cells in an autograft are predictive of posttransplant outcomes in multiple myeloma.
Cecilia BrownConferences | October 5, 2022
Noncryopreserved and cryopreserved peripheral blood stem cells (PBSC) lead to similar patient outcomes after transplant.
Cecilia BrownConferences | October 5, 2022
Most patients did not have extensive chronic GVHD after a mismatched transplant with this pretransplant conditioning regimen.
Cecilia BrownConferences | October 5, 2022
Patients transplanted with omidubicel had better quality of life than patients transplanted with umbilical cord blood.
Advertisement
Advertisement
Popular Stories